Patents by Inventor Birgit Werner

Birgit Werner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions
    Patent number: 9951093
    Abstract: The present invention relates to novel compounds that contain PNA units substituted with phosphonic acid ester functions or phosphonic acid functions, and have at least one chiral center. The compounds may be used for the treatment of viral diseases, such as AIDS.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: April 24, 2018
    Assignee: UGISense AG
    Inventors: Thomas Lindhorst, Birgit Werner, Holger Bock
  • PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS
    Publication number: 20170166900
    Abstract: The invention relates to new peptide nucleic acid monomers and peptide nucleic acid oligomers comprising a dialkylamine side chain substituted with phosphonic acid ester group(s) or phosphonic acid group(s), and to the uses thereof.
    Type: Application
    Filed: May 15, 2015
    Publication date: June 15, 2017
    Inventors: Thomas Lindhorst, Birgit Werner, Holger Bock
  • CHIRAL COMPOUNDS SUBSTITUTED WITH PHOSPHONIC ACID ESTER FUNCTIONS OR PHOSPHONIC ACID FUNCTIONS
    Publication number: 20130131019
    Abstract: The present invention relates to novel compounds that contain PNA units substituted with phosphonic acid ester functions or phosphonic acid functions, and have at least one chiral center. The compounds may be used for the treatment of viral diseases, such as AIDS.
    Type: Application
    Filed: June 19, 2012
    Publication date: May 23, 2013
    Applicant: Ugichem GmbH
    Inventors: Thomas Lindhorst, Birgit Werner, Holger Bock
  • Method for selective localization of active agents at and in mitochondria and corresponding active agents
    Patent number: 8362243
    Abstract: The present invention relates to novel methods for selective localization of active agents both at and in mitochondria within living cells, as well as corresponding active agents that penetrate through the cell membrane into the cells without further adjuvants and there can be localized both at and in mitochondria. These active agents are substituted with at least one monohydroxy mononitrophenyl rest or monohydroxy dinitrophenyl rest.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: January 29, 2013
    Assignee: Ugichem Gesellschaft fuer Organische Chemie mbH
    Inventors: Thomas Lindhorst, Birgit Werner, Stefan Piper
  • CHIRAL COMPOUNDS SUBSTITUTED WITH PHOSPHONATE ACID ESTER FUNCTIONS OR PHOSPHONIC ACID FUNCTIONS
    Publication number: 20100022478
    Abstract: The present invention relates to novel compounds that contain PNA units substituted with phosphonic acid ester functions or phosphonic acid functions, and have at least one chiral center. The compounds may be used for the treatment of viral diseases, such as AIDS.
    Type: Application
    Filed: July 20, 2007
    Publication date: January 28, 2010
    Inventors: Thomas Lindhorst, Birgit Werner, Holger Bock
  • METHOD FOR SELECTIVE LOCALIZATION OF ACTIVE AGENTS AT AND IN MITOCHONDRIA AND CORRESPONDING ACTIVE AGENTS
    Publication number: 20100009895
    Abstract: The present invention relates to novel methods for selective localization of active agents both at and in mitochondria within living cells, as well as corresponding active agents that penetrate through the cell membrane into the cells without further adjuvants and there can be localized both at and in mitochondria. These active agents are substituted with at least one monohydroxy mononitrophenyl rest or monohydroxy dinitrophenyl rest.
    Type: Application
    Filed: October 23, 2007
    Publication date: January 14, 2010
    Inventors: Thomas Lindhorst, Birgit Werner, Stefan Piper